CUA-CUOG Cnd Clinical Trials Update in GU: C4 Trials in GU [Prostate Cancer]
CUA-CUOG Canadian Clinical Trials Update in GU: C4 Trials in GU [Prostate Cancer]
EDITORIAL COMMITTEE: Ricardo Rendon, Andrew Loblaw, Sebastien Hotte
By the end of this presentation, participants will be able to:
- By focusing on key recent clinical trial reports, gain a better understanding of the evolving standard of care in men with prostate cancer with regards to:
- Surgical advances
- Radiation therapy
- Systemic therapy
- Get a sense of potential clinical trial options for their patients
- Be aware of upcoming trials that will likely further redefine the standard of care for men with high-risk and/or advanced prostate cancer
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.
This program has received financial support from Bayer.